| AEGFX | AIECX | AEGFX / AIECX | |
| Total Expense Ratio | 0.86 | 2.02 | 43% |
| Annual Report Gross Expense Ratio | 0.86 | 2.02 | 43% |
| Fund Existence | 25 years | 29 years | - |
| Gain YTD | 2.527 | 9.167 | 28% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 141B | 1.88B | 7,488% |
| Annual Yield % from dividends | 2.53 | 1.34 | 189% |
| Returns for 1 year | 5.43 | -4.86 | -112% |
| Returns for 3 years | 16.61 | -0.09 | -18,128% |
| Returns for 5 years | -5.92 | -37.36 | 16% |
| Returns for 10 years | 45.30 | -31.63 | -143% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LOTI | 26.23 | N/A | N/A |
| Liberty One Tactical Income ETF | |||
| INVG | 25.11 | -0.10 | -0.39% |
| Gmo Systematic Investment Grade Credit ETF | |||
| BCHP | 37.04 | -0.28 | -0.75% |
| Principal Focused Blue Chip ETF | |||
| BKIE | 99.40 | -1.01 | -1.01% |
| BNY Mellon International Equity ETF | |||
| HELX | 39.73 | -0.45 | -1.13% |
| Franklin Genomic Advancements ETF | |||